Search Results for: EGFR

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel PTPN7 protein tyrosine phosphatase non-receptor type 7
  • Negative regulation of MAPK pathway
  • Interleukin-37 signaling
Novel PTPRB protein tyrosine phosphatase receptor type B
  • Neutrophil degranulation
  • {4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID
  • (4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID
  • {4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID
  • (4-ETHYLPHENYL)SULFAMIC ACID
  • Razuprotafib
Novel PTPRH protein tyrosine phosphatase receptor type H
Novel PTPRJ protein tyrosine phosphatase receptor type J
  • Phosphorylation of CD3 and TCR zeta chains
  • Neutrophil degranulation
  • Negative regulation of MET activity
  • Negative regulation of FLT3
Novel PTPRR protein tyrosine phosphatase receptor type R
Novel PTPRS protein tyrosine phosphatase receptor type S
  • ECM proteoglycans
  • Receptor-type tyrosine-protein phosphatases
  • Synaptic adhesion-like molecules
  • Signaling by NTRK3 (TRKC)
  • Alendronic acid
  • Etidronic acid
Novel PTPRT protein tyrosine phosphatase receptor type T
Novel PTPRU protein tyrosine phosphatase receptor type U
  • Signaling by SCF-KIT
Novel RAB31 RAB31, member RAS oncogene family
  • Neutrophil degranulation
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
Novel RAB3A RAB3A, member RAS oncogene family
  • Serotonin Neurotransmitter Release Cycle
  • Norepinephrine Neurotransmitter Release Cycle
  • Glutamate Neurotransmitter Release Cycle
  • Dopamine Neurotransmitter Release Cycle
  • Acetylcholine Neurotransmitter Release Cycle
  • Neutrophil degranulation
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
  • GABA synthesis, release, reuptake and degradation
  • Sensory processing of sound by inner hair cells of the cochlea
Novel RAP1GDS1 Rap1 GTPase-GDP dissociation stimulator 1
  • RHOT2 GTPase cycle
  • RHOT1 GTPase cycle
Novel RAPGEF1 Rap guanine nucleotide exchange factor 1
  • Frs2-mediated activation
  • Frs2-mediated activation
  • Downstream signal transduction
  • MET activates RAP1 and RAC1
  • RAC3 GTPase cycle
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Regulation of signaling by CBL
Novel RASA1 RAS p21 protein activator 1
  • Downstream signal transduction
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • VEGFR2 mediated cell proliferation
  • Regulation of RAS by GAPs
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • RASA1-related disorders, including: Parkes-Weber slndrome; Capillary malformation-arteriovenous malformation (CM-AVM); Arteriovenous fistula (AVF)
Novel RGS16 regulator of G protein signaling 16
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
Novel RGS2 regulator of G protein signaling 2
  • G alpha (q) signalling events
Novel RGS4 regulator of G protein signaling 4
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
Novel RIMS2 regulating synaptic membrane exocytosis 2
Novel RIN1 Ras and Rab interactor 1
  • RAB GEFs exchange GTP for GDP on RABs
Novel RIN2 Ras and Rab interactor 2
  • RAB GEFs exchange GTP for GDP on RABs
  • Macrocephaly, alopecia, cutis laxa, and scoliosis; MACS syndrome
Novel RIPK1 receptor interacting serine/threonine kinase 1
  • Caspase activation via Death Receptors in the presence of ligand
  • TICAM1, RIP1-mediated IKK complex recruitment
  • RIP-mediated NFkB activation via ZBP1
  • TRIF-mediated programmed cell death
  • TRP channels
  • Regulation by c-FLIP
  • RIPK1-mediated regulated necrosis
  • CASP8 activity is inhibited
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NF-kappa-B signaling pathway
  • Regulation of necroptotic cell death
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • Dimerization of procaspase-8
  • TNF signaling
  • TLR3-mediated TICAM1-dependent programmed cell death
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • IKK complex recruitment mediated by RIP1
  • Potential therapeutics for SARS
  • Microbial modulation of RIPK1-mediated regulated necrosis
  • SARS-CoV-1-mediated effects on programmed cell death
  • Defective RIPK1-mediated regulated necrosis
  • Fostamatinib

Page 15 out of 42 pages